GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List

Range Low Price High Price Comment
30 days $65.50 $83.89 Friday, 19th Apr 2024 AXSM stock ended at $67.90. This is 3.32% more than the trading day before Thursday, 18th Apr 2024. During the day the stock fluctuated 4.03% from a day low at $65.50 to a day high of $68.14.
90 days $65.50 $98.40
52 weeks $55.03 $98.40

Historical Axsome Therapeutics prices

Date Open High Low Close Volume
2021-03-22 $64.87 $65.46 $62.96 $63.53 220 610
2021-03-19 $63.60 $64.91 $62.51 $64.60 534 407
2021-03-18 $67.42 $67.74 $62.13 $63.02 391 982
2021-03-17 $65.44 $68.38 $64.86 $68.08 287 822
2021-03-16 $65.42 $65.80 $63.69 $65.75 263 801
2021-03-15 $66.50 $66.75 $64.87 $65.22 297 229
2021-03-12 $67.29 $67.48 $65.25 $66.49 231 341
2021-03-11 $65.01 $68.12 $63.50 $67.48 356 900
2021-03-10 $66.08 $66.08 $63.95 $64.05 254 407
2021-03-09 $63.68 $66.93 $63.01 $64.90 298 409
2021-03-08 $64.69 $65.26 $62.62 $62.82 281 771
2021-03-05 $65.65 $66.00 $61.01 $65.02 465 882
2021-03-04 $69.85 $71.43 $65.81 $66.21 520 776
2021-03-03 $69.37 $71.49 $68.70 $70.18 246 796
2021-03-02 $70.01 $72.00 $69.10 $69.76 223 786
2021-03-01 $67.28 $71.74 $66.54 $69.20 473 108
2021-02-26 $68.33 $69.75 $66.01 $67.36 328 854
2021-02-25 $71.36 $72.75 $68.17 $68.38 279 625
2021-02-24 $70.58 $72.04 $69.40 $71.98 227 081
2021-02-23 $69.00 $70.70 $66.10 $69.93 393 361
2021-02-22 $71.98 $72.07 $69.20 $69.43 244 335
2021-02-19 $71.52 $73.15 $71.26 $72.27 290 048
2021-02-18 $71.30 $72.28 $70.01 $71.18 330 336
2021-02-17 $73.94 $74.24 $71.38 $72.02 281 042
2021-02-16 $75.25 $75.86 $74.10 $74.71 243 309
Click to get the best stock tips daily for free!

About Axsome Therapeutics

Axsome Therapeutics Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinical trial to treat Alzheimer's disease agitation, as well as that has completed phase II clinical trial ... AXSM Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT